Literature DB >> 19829034

Fournier's gangrene: a monographic urology center experience with twenty patients.

R Martínez-Rodríguez1, J Ponce de León, J Caparrós, H Villavicencio.   

Abstract

BACKGROUND: Fournier's gangrene (FG) is a fatal synergistic infectious disease with necrotizing fasciitis of the perineum and abdominal wall along with the scrotum and penis in males and the vulva in females. The aim of this study was to share our experience in the management of this infectious disease.
METHODS: A retrospective chart review was performed in 20 patients with a diagnosis of FG between January 1991 and December 2007. Patient's age, source and predisposing factors, microbiological findings, duration of hospital stay, treatment modalities, and outcome were analyzed.
RESULTS: The mean age of the patients was 53.9 +/- 9.56 (range 23-71) years. The source of gangrene was urinary in 5 patients, perirectal in 5, cutaneous in 1, and unknown in 9 patients. The main predisposing factors included diabetes mellitus in 9 patients (45%) and immunosuppression in 5 patients (25%). The mean duration of hospital stay was 39 +/- 10 (range 6-62) days. Although early intervention and intensive treatment were carried out, 4 patients died with an overall mortality of 20% as a result of septicemia complications. The mortality rate was higher in elderly patients and those with diabetes mellitus, but it was not statistically significant. Regarding the mortality rate, duration of symptoms, number of debridements, culture results and source of infection were not found to be significant factors.
CONCLUSIONS: FG is still a severe disease. Management of this infectious entity must be aggressive. Despite the use of contemporary effective antibiotic treatment, aggressive debridements, and state-of-the-art intensive-care conditions, FG still has high mortality and morbidity rates.

Entities:  

Mesh:

Year:  2009        PMID: 19829034     DOI: 10.1159/000241676

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  9 in total

1.  Prognostic Factors for Fournier's Gangrene; A 10-year Experience in Southeastern Iran.

Authors:  Amene Sabzi Sarvestani; Mehdi Zamiri; Mehdi Sabouri
Journal:  Bull Emerg Trauma       Date:  2013-07

Review 2.  [Dermatological diseases of the external male genitalia : Part 2: Infectious and malignant dermatological].

Authors:  F M Köhn; D Schultheiss; K Krämer-Schultheiss
Journal:  Urologe A       Date:  2016-07       Impact factor: 0.639

3.  Fournier's Gangrene: A Summary of 10 Years of Clinical Experience.

Authors:  Abdullah Oguz; Metehan Gümüş; Ahmet Turkoglu; Zübeyir Bozdağ; Burak Veli Ülger; Elif Agaçayak; Abdullah Böyük
Journal:  Int Surg       Date:  2015-04-10

Review 4.  [Dermatological diseases of the male genital tract].

Authors:  F-M Köhn
Journal:  Hautarzt       Date:  2016-10       Impact factor: 0.751

Review 5.  Contemporary diagnosis and management of Fournier's gangrene.

Authors:  Avinash Chennamsetty; Iyad Khourdaji; Frank Burks; Kim A Killinger
Journal:  Ther Adv Urol       Date:  2015-08

6.  The characteristics of oro-cervical necrotizing fasciitis-Comparison with severe cellulitis of oro-cervical region and necrotizing fasciitis of other body regions.

Authors:  Eiji Iwata; Junya Kusumoto; Naoki Takata; Shungo Furudoi; Akira Tachibana; Masaya Akashi
Journal:  PLoS One       Date:  2021-12-01       Impact factor: 3.240

7.  Necrotizing Soft Tissue Infection: A Single-Center Retrospective Study of Treatment and Outcomes.

Authors:  Dzemail Detanac; Mehmed Mujdragic; Dzenana A Detanac; Enes Zogic; Lejla Ceranic; Kemal Alihodzic; Mersudin Mulic; Hana Mujdragic
Journal:  Cureus       Date:  2021-05-15

8.  Fournier's Gangrene: Conventional Dressings versus Dressings with Dakin's Solution.

Authors:  Bülent Altunoluk; Sefa Resim; Erkan Efe; Mustafa Eren; Can Benlioglu; Nazim Kankilic; Halit Baykan
Journal:  ISRN Urol       Date:  2012-03-04

9.  A retrospective case series of Fournier's gangrene: necrotizing fasciitis in perineum and perianal region.

Authors:  Nan Zhang; Xin Yu; Kai Zhang; Tongjun Liu
Journal:  BMC Surg       Date:  2020-10-30       Impact factor: 2.102

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.